Differential IL-10 receptor gene expression in acute versus chronic atonic eczema. Modulation by immunosuppressive drugs and cytokines in normal cultured keratinocytes

Inflammation Research

Volumn 48, Issue 10, 1999, Pages 539-543

  Muschen A ^a   Mirmohammadsadegh, A ^a   Jarzebska Deussen, B ^a   Abts, H F ^a   Ruzicka, T ^a   Michel, G ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Atopic eczema; FK506; IL 10 receptor; Loratadine; Ultraviolet irradiation

Indexed keywords

CYTOKINE; GAMMA INTERFERON; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 10; INTERLEUKIN 10 RECEPTOR; INTERLEUKIN 4; LORATADINE; MESSENGER RNA; TACROLIMUS;

ARTICLE; ATOPIC DERMATITIS; CELL CULTURE; CONTROLLED STUDY; FLUORESCENCE IN SITU HYBRIDIZATION; GENE EXPRESSION REGULATION; HUMAN; HUMAN TISSUE; KERATINOCYTE; PATHOPHYSIOLOGY; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKIN BIOPSY; ULTRAVIOLET A RADIATION;

ACUTE DISEASE; ADULT; AGED; CELLS, CULTURED; CHRONIC DISEASE; CYTOKINES; DERMATITIS, ATOPIC; GENE EXPRESSION REGULATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KERATINOCYTES; MIDDLE AGED; RECEPTORS, INTERLEUKIN; RECEPTORS, INTERLEUKIN-10; RNA, MESSENGER; TACROLIMUS; ULTRAVIOLET THERAPY;

EID: 0032697703     PISSN: 10233830     EISSN: None     Source Type: Journal    
DOI: 10.1007/s000110050500     Document Type: Article

References (12)

1. 1 cells in the immunopathogenesis of atopic dermatitis. Immunol Today 1998; 19: 359-61.
2. Wang P, Wu P, Siegel MI, Egan RW, Billah MM. IL-10 inhibits transcription of cytokine genes in human peripheral blood mononuclear cells. J Immunol 1994; 153: 811-6.
3. Becherel PA, Legoff L, Ktorza S, Ouaaz F, Menciahuerta JM, Dugas B, et al. Interleukin-10 inhibits IgE-mediated nitric oxide synthase induction and cytokine synthesis in normal human keratinocytes. Eur J Immunol 1995; 25: 2992-5.
4. Beissert S, Hosoi J, Grabbe S, Asahina A, Granstein RD. IL-10 inhibits tumor antigen presentation by epidermal antigen-presenting cells. J Immunol 1995; 154: 1280-1286.
5. Fiorentino DF, Zlotnik A, Vieira P, Mosmann TR, Howard M, Moore KW, et al. IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells. J Immunol 1991; 146: 3444-51.
6. Ohmen JD, Hanifin JM, Nickoloff BJ, Rea TH, Wyzykowski R, Kim J, et al. Overexpression of IL-10 in atopic dermatitis. J Immunol 1995; 154: 1956-63.
7. Asadullah K, Sterry W, Stephanek K, Jasulaitis D, Leupold M, Audring H, et al. Il-10 is a key cytokine in psoriasis. J Clin Invest 1998; 101: 783-94.
8. Kotenko SV, Krause CD, Izotova LS, Pollak BP, Wu W, Pestka S. Identification and functional characterization of a second chain of the interleukin-10 receptor complex. EMBO J 1997; 16: 5894-903.
9. Michel G, Mirmohammadsadegh A, Olasz E, Jarzebska-Deussen B, Müschen A, Kemény L, et al. Demonstration and functional analysis of IL-10 receptors in human epidermal cells. Decreased expression in psoriatic skin, downmodulation by IL-8 and upregulation by an antipsoratic glucocorticosteroid in normal cultured keratinocytes. J Immunol 1997; 159: 6291-7.
10. Hanifin JM and Rajka G. Diagnostic features of atopic dermatitis. Acta Derm Venereol Suppl (Stockh) 1980; 92: 44-46
11. Ruzicka T, Bieber T, Schöpf E, Rubins A, Dobozy A, Bos JD, et al. A short-term trial of tacrolimus ointment for atopic dermatitis. N Engl J Med 1997; 337: 816-21.
12. Krutmann J, Czech W, Diepgen T, Niedner R, Kapp A, Schöpf E. High-dose UVA1 therapy in the treatment of patients with atopic dermatitis. J Am Acad Dermatol 1992; 26: 225-30.